Search research articles
Contact Us
Filters
Showing results (1-10 of 22) with videos related to
Page
of 3
Sort By:
NPJ Microgravity
|
December 2, 2022
Overview of lunar dust toxicity risk
Michael Pohlen, Danielle Carroll, G Kim Prisk, et al.
Surgical Endoscopy
|
July 22, 2024
Space surgery: a SAGES' white paper
Amanda Mueller, Eric Petersen, Danielle Carroll, et al.
Journal of Virology
|
June 9, 2017
Newcastle Disease Virus Establishes Persistent Infection in Tumor Cells <i>In Vitro</i>: Contribution of the Cleavage Site of Fusion Protein and Second Sialic Acid Binding Site of Hemagglutinin-Neuraminidase
Udaya S Rangaswamy, Weijia Wang, Xing Cheng, et al.
Analytical Biochemistry
|
June 17, 2005
Determining suitable internal standards for mRNA quantification of increasing cancer progression in human breast cells by real-time reverse transcriptase polymerase chain reaction
David L Morse, Danielle Carroll, Lyndon Weberg, et al.
Journal of Virology
|
March 25, 2016
Genetic Modification of Oncolytic Newcastle Disease Virus for Cancer Therapy
Xing Cheng, Weijia Wang, Qi Xu, et al.
Scientific Reports
|
February 18, 2022
Concomitant KRAS mutations attenuate sensitivity of non-small cell lung cancer cells to KRAS G12C inhibition
Tereza Vaclova, Atanu Chakraborty, James Sherwood, et al.
Elife
|
December 14, 2018
Structured illumination microscopy combined with machine learning enables the high throughput analysis and classification of virus structure
Romain F Laine, Gemma Goodfellow, Laurence J Young, et al.
NMR in Biomedicine
|
November 20, 2008
Characterization of breast cancers and therapy response by MRS and quantitative gene expression profiling in the choline pathway
David L Morse, Danielle Carroll, Sam Day, et al.
Mabs
|
December 9, 2014
Phage display and hybridoma generation of antibodies to human CXCR2 yields antibodies with distinct mechanisms and epitopes
Christine J Rossant, Danielle Carroll, Ling Huang, et al.
Molecular Cancer Therapeutics
|
March 6, 2026
Capivasertib combines with trastuzumab deruxtecan to enhance anti-tumour activity in HER2-positive and HER2-low tumours
Azadeh C Bashi, Theresa A Proia, Mandy Lawson, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 22) with videos related to
Sort By:
Page
of 3
NPJ Microgravity
|
December 2, 2022
Overview of lunar dust toxicity risk
Michael Pohlen, Danielle Carroll, G Kim Prisk, et al.
Surgical Endoscopy
|
July 22, 2024
Space surgery: a SAGES' white paper
Amanda Mueller, Eric Petersen, Danielle Carroll, et al.
Journal of Virology
|
June 9, 2017
Newcastle Disease Virus Establishes Persistent Infection in Tumor Cells <i>In Vitro</i>: Contribution of the Cleavage Site of Fusion Protein and Second Sialic Acid Binding Site of Hemagglutinin-Neuraminidase
Udaya S Rangaswamy, Weijia Wang, Xing Cheng, et al.
Analytical Biochemistry
|
June 17, 2005
Determining suitable internal standards for mRNA quantification of increasing cancer progression in human breast cells by real-time reverse transcriptase polymerase chain reaction
David L Morse, Danielle Carroll, Lyndon Weberg, et al.
Journal of Virology
|
March 25, 2016
Genetic Modification of Oncolytic Newcastle Disease Virus for Cancer Therapy
Xing Cheng, Weijia Wang, Qi Xu, et al.
Scientific Reports
|
February 18, 2022
Concomitant KRAS mutations attenuate sensitivity of non-small cell lung cancer cells to KRAS G12C inhibition
Tereza Vaclova, Atanu Chakraborty, James Sherwood, et al.
Elife
|
December 14, 2018
Structured illumination microscopy combined with machine learning enables the high throughput analysis and classification of virus structure
Romain F Laine, Gemma Goodfellow, Laurence J Young, et al.
NMR in Biomedicine
|
November 20, 2008
Characterization of breast cancers and therapy response by MRS and quantitative gene expression profiling in the choline pathway
David L Morse, Danielle Carroll, Sam Day, et al.
Mabs
|
December 9, 2014
Phage display and hybridoma generation of antibodies to human CXCR2 yields antibodies with distinct mechanisms and epitopes
Christine J Rossant, Danielle Carroll, Ling Huang, et al.
Molecular Cancer Therapeutics
|
March 6, 2026
Capivasertib combines with trastuzumab deruxtecan to enhance anti-tumour activity in HER2-positive and HER2-low tumours
Azadeh C Bashi, Theresa A Proia, Mandy Lawson, et al.
Page
of 3